Vaxart Inc (NASDAQ:VXRT)

5.51
Delayed Data
As of Apr 09
 -0.16 / -2.82%
Today’s Change
1.63
Today|||52-Week Range
24.90
-3.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$648.9M

Company Description

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.

Contact Information

Vaxart, Inc.
170 Harbor Way
South San Francisco California 94080
P:(650) 550-3500
Investor Relations:

Employees

Shareholders

Mutual fund holders18.72%
Other institutional13.33%
Individual stakeholders1.13%

Top Executives

Andrei FloroiuPresident CEO, CFO & Director
Sean N. TuckerChief Scientific Officer & Senior Vice President
Richard SchwartzSenior Vice President-Technical Operations
Shaily Jaini GargSVP-Clinical Development & Project Management
Margaret A. EcherdChief Accounting Officer & Senior Vice President